Established in 2002, Renogenic Sdn Bhd is a pioneering Malaysian biotechnology company involved in the research and development of various biotechnology applications utilizing molecular recognition technologies and molecular biology. Backed by a team of talented scientists and state-of-the art facilities, Renogenic specializes in the development of innovative drug residue and drugs of abuse detection kits, among others.

Since Watson and Crick's description of DNA in 1953, to the mapping of the human genome in 2000, biotechnology is considered a young science yet has quickly grown in prominence around the world. Many triumphs of modern medicine and new diagnostic and therapeutic methods can be attested to the science of biotechnology. Answering Malaysia's call to develop the nation's biotechnology industry, Renogenic is spearheading biotechnological research and development in fast and user-friendly test kits. These kits are already making an impact on the market with many more pipeline products to be officially launched soon.

Renogenic is steadfastly committed to delivering the highest quality products and services. This commitment is driven by the country's leading biotechnology research and development team and advanced research labs and facilities. Excellence is ensured through research methodologies that adhere to the highest industry standards and procedure protocols.

A strategic partnership with Universiti Sains Malaysia (USM) allows Renogenic access to leading research consultants, technologies, and facilities. Renogenic collaborates closely with clients, distributors and research alliances to engineer effective solutions, improve existing products and advance on-going product development.